Pharmafile Logo
Pharmafocus logo
Advanced Search

cymbalta

Showing 6 posts of 6 posts found.

Lilly set for Cymbalta lawsuit showdown

August 5, 2015
Research and Development cymbalta, duloxetine, lawsuit, lilly

Lilly is contesting the first in a series of lawsuits brought by patients who say the company failed to inform …

News
Lilly image

Lilly and Novartis face legal challenges

June 25, 2015
Medical Communications, Sales and Marketing Gleevec, Glivec, Novartis, cymbalta, imatinib, lilly, zyprexa

Judges in California have ruled that Lilly should face claims it failed to fully disclose the extent of post-withdrawal side …

News
Lilly image

Lacklustre sales hit Lilly again

October 24, 2014
Sales and Marketing Q3, cymbalta, humilin, lilly, sales, zyprexa

Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out …

News
Lilly image

Lilly to go ‘on offense’

January 31, 2014
Sales and Marketing Alimta, Lechleiter, cymbalta, lilly, q4, zyprexa

The loss of patent on antidepressant Cymbalta in the US last December was largely responsible for Eli Lilly & Co’s …

News
Lilly image

Lilly beats estimates with solid Q2 performance

July 26, 2013
Sales and Marketing Q2, cymbalta, lilly, zyprexa

Lilly posted a healthy set of financials at the end of July as the company looks to keep its growth …

News

Promise for Lundbeck and Takeda’s depression drug

May 20, 2013
Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly

Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026